Targeted therapy for non-small-cell lung cancer: past, present and future.
Targeted therapy for non-small-cell lung cancer: past, present and future.
复制标题
DOI:
10.1586/era.13.47
复制
发表时间:
2013-06
影响因子:
3.3
通讯作者:
Ettinger DS
中科院分区:
文献类型:
--
作者:
Forde PM;Ettinger DS
Therapy for advanced non-small-cell lung cancer has developed significantly with new awareness of histologic subtype as an important factor in guiding treatment and the development of targeted agents for molecular subgroups harboring critical mutations that spur on cancer growth. In this comprehensive review, we look back at developments in targeted therapy for advanced non-small-cell lung cancer, reviewing in detail efforts, both successful and in some cases less so, to target EGFR, VEGF and ALK. This review provides an overview of where the field stands at present and the areas we feel are most likely to provide challenges and potential successes in the next 5 years including immune checkpoint inhibition, epigenetic therapy and driver mutation targeting.
登录
查看更多内容
DOI:
10.1016/s1470-2045(10)70132-7
发表时间:
2010-07
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Herbst RS;Sun Y;Eberhardt WE;Germonpré P;Saijo N;Zhou C;Wang J;Li L;Kabbinavar F;Ichinose Y;Qin S;Zhang L;Biesma B;Heymach JV;Langmuir P;Kennedy SJ;Tada H;Johnson BE
通讯作者:
Johnson BE
影响因子:
45.3
作者:
Giaccone, G;Herbst, RS;Johnson, DH
通讯作者:
Johnson, DH
影响因子:
30.8
作者:
Cameron, EE;Bachman, KE;Baylin, SB
通讯作者:
Baylin, SB
DOI:
10.1056/nejmoa1200694
发表时间:
2012-06-28
期刊:
The New England journal of medicine
影响因子:
--
作者:
Brahmer JR;Tykodi SS;Chow LQ;Hwu WJ;Topalian SL;Hwu P;Drake CG;Camacho LH;Kauh J;Odunsi K;Pitot HC;Hamid O;Bhatia S;Martins R;Eaton K;Chen S;Salay TM;Alaparthy S;Grosso JF;Korman AJ;Parker SM;Agrawal S;Goldberg SM;Pardoll DM;Gupta A;Wigginton JM
通讯作者:
Wigginton JM
影响因子:
45.3
作者:
Goss, Glenwood D.;Arnold, Andrew;Seymour, Lesley
通讯作者:
Seymour, Lesley